Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015–2017

dc.contributor.authorPeirano, Gisele
dc.contributor.authorChen, Liang
dc.contributor.authorNobrega, Diego
dc.contributor.authorFinn, Thomas J.
dc.date.accessioned2023-06-08T05:12:28Z
dc.date.available2023-06-08T05:12:28Z
dc.date.issued2022-05
dc.description.abstractWe describe the global molecular epidemiology of 229 carbapenemase-producing Escherichia coli in 36 countries during 2015–2017. Common carbapenemases were oxacillinase (OXA) 181 (23%), New Delhi metallo-β-lactamase (NDM) 5 (20%), OXA-48 (17%), Klebsiella pneumoniae carbapenemase 2 (15%), and NDM-1 (10%). We identified 5 dominant sequence types (STs); 4 were global (ST410, ST131, ST167, and ST405), and 1 (ST1284) was limited to Turkey. OXA-181 was frequent in Jordan (because of the ST410-B4/H24RxC subclade) and Turkey (because of ST1284). We found nearly identical IncX3-blaOXA-181 plasmids among 11 STs from 12 countries. NDM-5 was frequent in Egypt, Thailand (linked with ST410-B4/H24RxC and ST167-B subclades), and Vietnam (because of ST448). OXA-48 was common in Turkey (linked with ST11260). Global K. pneumoniae carbapenemases were linked with ST131 C1/H30 subclade and NDM-1 with various STs. The global carbapenemase E. coli population is dominated by diverse STs with different characteristics and varied geographic distributions, requiring ongoing genomic surveillance.en_US
dc.description.departmentMedical Microbiologyen_US
dc.description.librarianam2023en_US
dc.description.sponsorshipThe Joint Programming Initiative on Antimicrobial Resistance–Canadian Institute Health Research program and the US National Institutes of Health.en_US
dc.description.urihttp://wwwnc.cdc.gov/eiden_US
dc.identifier.citationPeirano, G., Chen, L., Nobrega, D. et al. 2022, 'Genomic epidemiology of global carbapenemase-producing escherichia coli, 2015–2017', Emerging Infectious Diseases, vol. 28, no. 5, pp. 924-931, doi : 10.3201/eid2805.212535. .en_US
dc.identifier.issn1080-6040 (print)
dc.identifier.issn1080-6059 (online)
dc.identifier.other10.3201/eid2805.212535
dc.identifier.urihttp://hdl.handle.net/2263/91048
dc.language.isoenen_US
dc.publisherCenters for Disease Control and Preventionen_US
dc.rights© 2022, Centers for Disease Control and Prevention (CDC). All rights reserved.en_US
dc.subjectSurveillanceen_US
dc.subjectCarbapenemasesen_US
dc.subjectMolecular epidemiologyen_US
dc.subjectEscherichia colien_US
dc.subjectBacteriaen_US
dc.subjectWhole-genome sequencing (WGS)en_US
dc.subjectAntimicrobial resistance (AMR)en_US
dc.titleGenomic epidemiology of global carbapenemase-producing Escherichia coli, 2015–2017en_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Peirano_Genomic_2022.pdf
Size:
549.7 KB
Format:
Adobe Portable Document Format
Description:
Article
Loading...
Thumbnail Image
Name:
Peirano_GenomicSuppl_2022.pdf
Size:
403.13 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Material

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: